David Schnell
InvestorManaging Director at Prospect Venture Partners · Board director at Ngm Biopharmaceuticals
Menlo Park, California
About
David Schnell is a Managing Director who co-founded Prospect Ventures in 1997, a firm focused on biomedical companies. He was previously a Partner at Kleiner Perkins Caufield & Byers, where he invested in early-stage biotechnology companies, and co-founded and served as CEO of Healtheon Corporation, which later merged with WebMD. Earlier he spent seven years at Sandoz Pharmaceuticals (now Novartis) in executive roles; he holds an MD from Harvard Medical School and an MA and BS from Stanford.
Contact· self-published, not guessed
Invests in
Biotech
Board director at Ngm Biopharmaceuticals
Intro paths
In turn, David can intro founders to Ngm Biopharmaceuticals's investors below.
Ngm Biopharmaceuticals's investors · 3
Co-founders at Ngm Biopharmaceuticals
Investments
Board seats
AmiraGloucester PharmaceuticalsKythera BiopharmaceuticalsNgm BiopharmaceuticalsRinat NeurosciencesSenomyxTrubion
Per the firm's website.
Colleagues at Prospect Venture Partners
Frequently asked questions
- Who is David Schnell?
- David Schnell is a Managing Director who co-founded Prospect Ventures in 1997, a firm focused on biomedical companies. He was previously a Partner at Kleiner Perkins Caufield & Byers, where he invested in early-stage biotechnology companies, and co-founded and served as CEO of Healtheon Corporation, which later merged with WebMD. Earlier he spent seven years at Sandoz Pharmaceuticals (now Novartis) in executive roles; he holds an MD from Harvard Medical School and an MA and BS from Stanford.
- Where does David Schnell work?
- David Schnell is Managing Director at Prospect Venture Partners and Board director at Ngm Biopharmaceuticals.
- What does David Schnell invest in?
- David Schnell invests in Biotech.
- What boards does David Schnell sit on?
- David Schnell holds tracked board seats at Amira, Gloucester Pharmaceuticals, Kythera Biopharmaceuticals, Ngm Biopharmaceuticals, Rinat Neurosciences, Senomyx, Trubion.